The European Lung Foundation (ELF)Founded by ERS in 2000, ELF brings together patients and the public with respiratory professionals to positively influence lung health.Visit the ELF site
ERS Lung Science ConferenceJoin us for this year’s virtual event (11–12 March). The theme is ‘Repair and regeneration in chronic lung disease and lung cancer’.Find out more/register
Sleep and Breathing 2021Taking place in April, this is the largest pan-European meeting of its kind and offers an integrated approach to the investigation and treatment of sleep disorders.Find out more/register
This event is the first of a series of live panel discussions available on the new ERS Respiratory Channel. The event is completely free to access but registration is required.
Overview
In a time of extreme difficulty, with unprecedented pressure on health systems, this live discussion will focus on the positive outcomes of the COVID-19 pandemic – highlighting the response of key stakeholders in terms of innovation and improved communications and collaborations, which all help to deliver better outcomes for patients and support healthcare systems worldwide.
The discussion will feature a high-profile panel who represent some of the key stakeholders involved in these developments. The discussion areas will include:
Distribution and supply of essential medicines and medical devices.
Novel vaccine development, regulatory approval and delivery.
Rapid trials for evaluation of new therapies, vaccines, and respiratory devices in a pandemic.
Better communications/digital health and support for healthcare professionals – and between all key stakeholders.
The panel
ERS President Prof. Anita Simonds and ERS Science Council Chair Prof. Christopher E. Brightling will lead the discussion. They will be joined by a high-profile panel:
Dr. Hans Kluge – WHO Regional Director for Europe
Manuela Buxo – Head of Europe at Sanofi Genzyme
Sir Stephen Holgate – Clinical Professor of Immunopharmacology, University of Southampton/Co-founder of Synairgen
Sir Menelas Pangalos, EVP & President BioPharmaceuticals R&D, AstraZeneca
Katrin Pucknat – CEO and President, ResMed Germany
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.